Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles. We use a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.
We are focused on breakthrough opportunities at the intersection of tech and biotech, with a deeply technical investment team. Our thesis-driven investment process systematically identifies key undercurrents driving change.Learn More
We fund the visionaries who are transforming healthcare.Learn More
The Foresite Capital team has the experience, insights and connections needed to find and support visionaries who are changing the world.Learn More
“The Foresite Capital team has been fantastic to work with, particularly as we've transitioned from a startup to a growth stage company. We’ve collaborated closely on a number of different points: financing, recruiting and strategy for example. It’s a true partnership.”
Nima Farzan, CEO
"Foresite Capital has been a visionary partner."
Serge Saxonov, CEO & Co-Founder
“Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance.”
"The Foresite team contributed meaningful scientific and strategic insights that supported our path from concept to acquisition in just over two years. Their partnership allowed our small team to move more quickly and decisively than we could have alone."
"The Foresite Capital team has been great collaborators as we work to push the bounds of what is possible when disparate healthcare data can be combined and accessed in a privacy-compliant manner."
Foresite Capital has championed the growth of Eikon Therapeutics from a simple whiteboard exercise through its transformation into a powerful, clinical-stage biopharmaceutical company. They have been an ideal strategic partner throughout our extraordinary journey.
Roger M. Perlmutter